Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Biotechnology

Health Care

Pharmaceutical

Outpace Bio

Marc Lajoie

Sydney Klatt

Catherine Pham

Scott Boyken

Eric Soller

Aaron Foster

The Leadership Team at Outpace Bio formulates and steers the company's strategic vision, overseeing the development and execution of high-impact biotechnology solutions. Comprising key executives such as the Co-Founder and CEO, Chief Scientific Officer, Co-Founder and CTO, and CBO, the team drives innovation, fosters key partnerships, and ensures alignment with the company's mission to advance smart cell therapies for a variety of complex diseases.

Leadership Team

Scientific Research Team

Leadership Team

About

Team members

Other teams at Outpace Bio

Scientific Research Team